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The pathogenicity of the primate lentiviruses, human, and simian immunodeficiency viruses, is host-specific. Previous studies indicated that
the highly pathogenic human lentivirus HIV-1 has markedly reduced pathogenicity compared to the pathogenic simian lentivirus SIV in pigtail
macaques (Macaca nemestrina). We therefore hypothesized that the pigtail macaque peripheral blood mononuclear cells (mPBMCs) would
respond differently to infections of HIV-1 and pathogenic SIV. To elucidate the cellular responses to the infections of HIV-1 and SIV, we infected
mPBMC with these two viruses. Like infections in vivo, HIV-1 and SIV demonstrated distinct replication kinetics in mPBMCs, with HIV-1
replicating at significantly lower levels. Similarly, gene expression profiling facilitated by macaque-specific oligonucleotide microarrays also
revealed distinct expression patterns of genes between the HIV-1- and SIV-infected mPBMCs; in particular, genes associated with the antigen
presentation, T cell receptor, ERK/MAPK signaling, Wnt/β-catenin signaling, and natural killer cell signaling pathways were differentially
regulated between these two viruses. Most interestingly, despite the lower levels of replication, HIV-1 triggered a more robust regulation of
immune response genes early after infection; the converse was true in SIV-infected mPBMCs. Our results therefore suggest that macaques may be
controlling the infection of HIV-1 at an early stage through coordinated regulation of host defense pathways.
© 2007 Elsevier Inc. All rights reserved.Keywords: HIV-1; SIV; Macaque peripheral blood mononuclear cells; Microarray; Gene expressionIntroduction
The AIDS/macaque model is the most widely used
experimental system for studying host responses to the infection
of primate lentiviruses, especially human immunodeficiency
virus-2 (HIV-2) and simian immunodeficiency virus (SIV)
(Kaizu et al., 2006; Lichterfeld et al., 2005). Although human
immunodeficiency virus-1 (HIV-1) and SIV share limited
sequence identity (Franchini and Bosch, 1989), infection of
SIV in macaques could closely resemble the infection of HIV-1
in humans, as characterized by the gradual depletion of CD4+ T
cells symptomatic of AIDS, which causes a dysfunctional
immune system and eventual death (Mattapallil et al., 2005).
Interestingly, HIV-1, the main pathogen causing AIDS in⁎ Corresponding author. Fax: +1 206 732 6055.
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doi:10.1016/j.virol.2007.04.020human (Simon et al., 2006), demonstrated a minimal pathogenic
phenotype in macaques (Agy et al., 1992, 1997; Gartner et al.,
1994).
Recent studies suggested that cellular factors may impose
restrictive effects on the HIV-1 replication in macaques (Zheng
and Peterlin, 2005). Macaque APOBEC3G/F inhibits HIV-1
replication by introducing hypermutations during reverse
transcription (Zennou and Bieniasz, 2006). Macaque TRIM5
was able to decrease HIV-1 replication also at the step of reverse
transcription (Wu et al., 2006). Although these host factors may
significantly hinder HIV-1 replication in vitro (Hatziioannou et
al., 2006; Kamada et al., 2006), whether they are the sole
determinants for the loss of HIV-1 pathogenicity in macaques is
still elusive. Lines of evidence suggest that the dissociation of
the replicative capacity and the pathogenicity of primate
lentiviruses indeed occurred in nonhuman primates (Broussard
et al., 2001; Pandrea et al., 2003; Silvestri et al., 2003). More
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can become highly pathogenic during infections in macaques
(Beer et al., 2005). Therefore, it would be reasonable to
speculate that the loss of pathogenicity of HIV-1 in macaques is
not solely attributed to its decreased replicative capacity in
macaque cells.
Increasing evidence indicates that the patterns of cellular
response to the infections of a variety of viruses could well
reflect their pathogenic properties (Kash et al., 2004,
2006a,2006b; Kobasa et al., 2007; Ploquin et al., 2006; Wang
et al., 2005). Distinct responses by TGF-β signaling were
observed between infections of pathogenic and nonpathogenic
SIV strains in nonhuman primates (Ploquin et al., 2006).
Proinflammatory and cell death pathways were found to be
differentially regulated in mice infected by influenza viruses
with various pathogenic properties (Kash et al., 2004, 2006b).
Similarly, the interferon response and immune evasion path-
ways were seen to be regulated differently in human as well as
mouse cells during the infections by highly pathogenic and
lowly pathogenic filoviruses (Kash et al., 2006a) and rabies
viruses (Wang et al., 2005), respectively. Therefore, we
hypothesized that the infections of HIV-1 and pathogenic SIV
would induce distinct cellular responses in macaque peripheral
blood mononuclear cells (mPBMCs).
A comparison of the cellular responses of mPBMCs to the
infections of primate lentiviruses with different pathogenic
properties would greatly improve our understanding of the
pathogenesis of primate lentiviruses. To gain further insights
into the cellular responses to the HIV-1 and pathogenic SIV, we
infected pigtail macaque PBMCs with an HIV-1 strain and a
highly pathogenic SIV strain (Batten et al., 2006). By usingFig. 1. (A) Indirect Immunofluorescence Assay (IFA) in mPBMCs infected for 6 days
cells in the experiments. On the left are the immunofluorescence analyses of the ident
of under 1%, while the infection rate for the SIV-infected culture was under 2% on day
1-infected and SIV-infected cultures. The data shown here are representative of mPB
with HIV-1 and SIV, along with the mock. The data shown here are a summary of mmacaque specific oligonucleotide microarrays, we were able to
elucidate the cellular gene expression changes in mPBMCs in
response to HIV-1 and SIV infections. Our results suggested
that an enhanced early immune response distinguished the HIV-
1 infection from the SIV infection in mPBMCs and could be a
major contributing factor to reduced HIV-1 pathogenicity in
macaques.
Results and discussion
HIV-1 and SIV demonstrate distinct infection kinetics in the
pigtail macaque PBMC cultures
To evaluate the infections of HIV-1 and SIV in mPBMCs,
we infected mPBMCs with a nonpathogenic HIV-1 strain
along with a highly pathogenic SIV strain at the same multi-
plicity of infection (1 TCID50/cell). Both HIV-1 and SIV
strains used in this study were T-tropic viruses that primarily
infect CD4+ T cells (Kestler et al., 1990; Peden et al., 1991).
We examined the cell distributions of mPBMCs prior to in-
fections using flow cytometry. mPBMCs from 3 individual
macaques showed comparable compositions in term of cell
types present (Supplemental Table 1) and were used in the
infection experiments.
During the infections in mPBMCs, HIV-1 and SIV de-
monstrated distinct replication kinetics. Although mPBMCs
can be infected by both viruses, only a small portion of cells
were actually infected in HIV-1 or SIV cultures (Fig. 1A).
Infected cells were not noticeable in either HIV-1- or SIV-
infected mPBMC cultures until day 4 post-infection (p.i.) (data
not shown). Even with a higher percentage of infected cells inwith HIV-1and SIV. On the right are phase contrast micrographs of virus-infected
ical microscopic field. (B) The HIV-1-infected culture exhibited an infection rate
6 p.i. There were approximately the same numbers of cells counted in both HIV-
MCs infection from 3 animals. (C) The viabilities of mPBMC cultures infected
PBMCs infections from 3 animals.
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were estimated to be infected by HIV-1 and under 2% of the
cells were infected by SIV (Fig. 1B). Through the course of
infections, cell viability of neither virus-infected mPBMC
cultures differed from mock-infected mPBMC cultures, until a
surge in cell death is seen in the SIV-infected cultures on day
8 p.i. (Fig. 1C). As a well-accepted parameter for the replication
status of HIV/SIV, we measured Gag protein levels in HIV-1-
and SIV-infected mPBMCs (Fig. 2A). Given that the SIV Gag
level was more than 50-fold higher than that of HIV-1 Gag on
both days 4 and 6 p.i., and that there was not a significantly
higher number of cells infected by SIV than infected by HIV-1
in the cultures (Fig. 1), SIV replication appeared to be more
robust than HIV-1 replication in mPBMCs (Kamada et al.,
2006). The relative abundance of the viral genome RNA
measured by real-time PCR assays also indicated that the SIV
genome RNA increased more robustly than the HIV-1 genome
RNA during the infection in mPBMCs (Fig. 2B). The
abundance of the HIV-1 genome temporally increased during
HIV-1 infection and peaked on day 6 p.i., then decreased on dayFig. 2. (A) Levels of gag protein (Gagp24-HIV-1 and Gagp27-SIV) reflect the
progression of viral infection. The graph tracks the average gag levels for
PBMCs from all three infected animals through 8 days post-infection, with the
error bars reflecting individual variations. Both HIV-1- and SIV-infected
cultures showed progressing virus replication in the infected cultures. (B) Levels
of HIV-1 or SIV viral genomic RNA reflect the progression of viral replication.
The graph tracks the increase in the quantity the virus RNA genomes relative to
the quantity of the corresponding virus genomes on day 2 p.i. Data shown here
are a summary of mPBMCs infections from 3 animals.8 p.i. In contrast, the abundance of the SIV genome steadily
increased through the course of infection. Collectively, our data
suggested that HIV-1 replicated at significantly lower levels
compared to SIV in mPBMCs, consistent with the in vivo
results reported previously (Batten et al., 2006), possibly owing
in part to the presence of host restriction factors (Hatziioannou
et al., 2006; Kamada et al., 2006; Rodrigo et al., 1997).
HIV-1 and SIV induce cellular gene expression changes via
distinct kinetics
To profile the global cellular gene expression changes in
response to the infections of HIV-1 and SIV in mPBMCs, we
performed differential gene expression analysis using macaque-
specific oligonucleotide microarrays. Taking advantage of the
marked specificity of the macaque-specific oligonucleotide
microarrays, we adopted a 1% false-positive rate (p≤0.01) as
the threshold for selecting differentially expressed genes. We
profiled HIV-1-infected and SIV-infected cells from two time
points, days 4 and 6 p.i.; we excluded day 8 p.i. or later due to
the noticeable surge in cell death in the SIV-infected culture
after day 6 p.i. (Fig. 1C).
The global gene expression patterns of HIV-1- and SIV-
infected mPBMCs clearly indicated that despite less robust
replication, the HIV-1 infection induced a stronger cellular
response than the SIV infection at the earlier time point (Fig.
3A). Among ∼1300 cellular genes that had expression changes
in 1 out of 4 data points (Supplemental Table 4), 399 genes in
HIV-1 d4 and 107 genes in SIV d4 showed expression changes
(Fig. 3B), even though the HIV-1 replication was at signi-
ficantly lower levels than the SIV replication on day 4 p.i. On
day 6 p.i., the number of changed genes increased to 497 in the
SIV-infected mPBMCs but still fewer than the 587 genes in
HIV-1-infected mPBMCs. Thus, in spite of more subdued virus
replication, HIV-1 infection appeared to be able to induce a
similar, if not stronger, host response when compared to the
relatively more active SIV-1 infection.
Pathways analyses of the cellular gene expression profiles of
mPBMCs infected with HIV-1 and SIV
To characterize the different cellular responses induced by
the infection of HIV-1 or SIV in mPBMCs, we analyzed the lists
of differentially expressed genes during the infections of HIV-1
and SIV by Ingenuity Pathway Analysis (IPA), a knowledge-
based pathway analysis tool used in previous studies (Bowick et
al., 2006; Li et al., 2005; Pasieka et al., 2006; Thomas et al.,
2006). In brief, functions of cellular genes are mined from peer-
reviewed literatures and manually curated into the knowledge-
base. A network analysis of the knowledgebase is used to
construct interaction-based relationships between proteins in the
knowledgebase. Furthermore, while our differentially expressed
genes were scattered across most of the networks in the
knowledgebase, IPA ranks the networks based on the number of
differentially expressed genes in one network as a percentage of
the total number of genes in the network. In the discussion
below, we focused on the top-ranking networks, as they
Fig. 4. Pathways that were affected in the HIV-1-infected or SIV-infected
mPBMCs. The Ingenuity Pathway Analysis software was used to generate lists
of pathways. The IPA annotation designates the differentially expressed genes in
HIV-1-infected or SIV-infected mPBMCs into different pathways. The antigen
presentation, T cell receptor, ERK/MAPK signaling, Wnt/β-catenin signaling,
and the natural killer cell signaling pathways were seen to be significantly
impacted by HIV-1 or SIV infections in mPBMCs. The two histograms represent
data from signature genes, defined as having a p≤0.01. The p-value is derived
from both the errors in microarray measurements and the estimated variance
among the 3 animals.
Fig. 3. (A) Hierarchical cluster of global gene expression patterns of mPBMC
infected with HIV-1 and SIV. Each gene in the cluster passed the statistical cutoff
(p≤0.01) at least once in 4 data points based on the Rosetta error model in
Resolver. Every expression value shown in this report is the average expression
value from 3 individual animals. Genes having increased expression values
compared to time matched mock were shown as red while the genes having
decreased expression values compared to time matched mock were shown as
green. (B) The number of signature genes that have expression changes
(p≤0.01) in HIV-1-infected or SIV-infected mPBMC on days 4 or 6 p.i. The two
histograms represent data from signature genes, defined as having a p≤0.01.
The p-value is derived from both the errors in microarray measurements and the
estimated variance among the 3 animals.
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differentially expressed genes.
In other words, the IPA analyses suggested that these
pathways, as described below, exhibited differential expression
upon HIV-1 and SIV infection in mPBMCs, with some being
unique to HIV-1 or SIV infection (Fig. 4).
Pathway analyses of the cellular gene expression profiles in
HIV-1-infected mPBMCs
Antigen presentation pathway
Nine genes associated with the antigen presentation pathway
(Table 1A) showed expression changes in the HIV-1-infectedmPBMCs. Among these 9 genes, 6 genes belonged to the MHC
class II family, including CD74, HLA-DMA, HLA-DMB,
HLA-DRA, HLA-DRB1, and HLA-DRB5 (Fig. 5A). HLA-DM
molecules (HLA-DMA and HLA-DMB) are known to be
necessary for the formation of the antigen presentation complex
(Fling et al., 1994) and to enhance the MHC/antigen binding
(Sherman et al., 1995). The interaction between HLA-DR
(HLA-DRA, HLA-DRB1, and HLA-DRB5) and HLA-DM
(HLA-DMA and HLA-DMB) was shown to be crucial in
preventing immune evasion (Zwart et al., 2005). The up-
regulation of all these genes suggested that the MHC class II
mediated antigen presentation may be enhanced in the HIV-1-
infected mPBMCs. Furthermore, an MHC class I gene (HLA-
A) was also up-regulated only in the HIV-1-infected mPBMCs.
HLA-A presents endogenous antigens to the CD8+ T cells,
which in turn play crucial roles in the anti-viral immune
responses against HIV-1 infection in human cells (Levy, 2003;
Lichterfeld et al., 2005). In addition, the interaction between
MHC I and CD74 play is possibly involved in antigen
presentation (Powis, 2006). By TaqMan qRT-PCR, we also
confirmed the up-regulation of CD74 by HIV, but not SIV (Fig.
7). Collectively, the up-regulation of MHC-class I/II molecules
may point to an up-regulation of antigen presentations during
the HIV-1 infection compared to the SIV infection in macaques,
which may in turn enhance immune surveillance and account
for the subdued pathogenicity of HIV.
T cell receptor pathway
MHC class I/II molecules primarily present antigens to
CD4+ or CD8+ T cells through coupling with the T cell receptor
complex (TCR/CD3). It may consequently induce the T cell-
mediated immune responses (Carreno et al., 2006).
Exogenous signals from MHC could be transduced into T
cells via CD247 (CD3-zeta) (Sancho et al., 1992) and CD247-
associated molecules, including ZAP-70, LCK, and FYN
Table 1
The expression pattern of the genes associated with the pathways affected in
HIV-1-infected and SIV-infected mPBMCs
A




NM_004355 CD74 Up-regulated Unch.
NM_002116 HLA-A Up-regulated Unch.
NM_006120 HLA-DMA Up-regulated Unch.
NM_002118 HLA-DMB Up-regulated Unch.
NM_019111 HLA-DRA Up-regulated Unch.
NM_002124 HLA-DRB1 Up-regulated Unch.
NM_002125 HLA-DRB5 Up-regulated Unch.
NM_002798 PSMB6 Down-regulated Unch.
NM_004159 PSMB8 Down-regulated Down-regulated
T cell receptor pathway
NM_198053 CD247 Up-regulated Unch.
NM_001768 CD8A Up-regulated Unch.
NM_004931 CD8B Up-regulated Up-regulated
NM_005214 CTLA4 Down-regulated Down-regulated
NM_002037 FYN Up-regulated Unch.
NM_005356 LCK Up-regulated Unch.
NM_002746 MAPK3 Up-regulated Unch.
NM_001079 ZAP70 Up-regulated Unch.
ERK/MAPK signaling pathway
NM_004418 DUSP2 Up-regulated Unch.
NM_001946 DUSP6 Up-regulated Unch.
NM_002037 FYN Up-regulated Unch.
NM_002107 H3F3A Up-regulated Unch.
NM_002746 MAPK3 Up-regulated Unch.
NM_002661 PLCG2 Up-regulated Unch.
NM_005167 PPM1J Up-regulated Up-regulated
NM_001008709 PPP1CA Up-regulated Unch.
NM_002730 PRKACA Up-regulated Unch.
NM_002732 PRKACG Up-regulated Up-regulated
NM_001010935 RAP1A Down-regulated Unch.
NM_001006665 RPS6KA1 Up-regulated Unch.
NM_003131 SRF Down-regulated Unch.
NM_007315 STAT1 Down-regulated Unch.
NM_006289 TLN1 Up-regulated Unch.
NM_003405 YWHAH Up-regulated Unch.
B




NM_145259 ACVR1C Down-regulated Unch.
NM_016269 LEF1 Down-regulated Unch.
NM_181674 PPP2R2B Up-regulated Unch.
NM_003199 TCF4 Down-regulated Unch.
C
Accession # Primary sequence
name
HIV-1 SIV
Natural killer cell pathway
NM_002983 CCL3 Down-regulated Up/Down-regulated
NM_002984 CCL4 Up-regulated Unch.
NM_002985 CCL5 Up-regulated Unch.
NM_016382 CD244 Up-regulated Up-regulated
NM_000569 FCGR3A Up-regulated Unch.
NM_005541 INPP5D Up-regulated Unch.
C
Accession # Primary sequence
name
HIV-1 SIV
Natural killer cell pathway
NM_014218 KIR2DL1 Up-regulated Up-regulated
NM_014219 KIR2DL2 Up-regulated Unch.
NM_013289 KIR3DL1 Up-regulated Up-regulated
NM_006737 KIR3DL2 Up-regulated Unch.
NM_002259 KLRC1 Up-regulated Up-regulated
NM_002260 KLRC2 Up-regulated Up-regulated
NM_002262 KLRD1 Up-regulated Unch.
NM_002831 PTPN6 Down-regulated Unch.
NM_003177 SYK Up-regulated Up-regulated
NM_003332 TYROBP Up-regulated Up-regulated
(A) The expression pattern of genes associated with the pathways unique in the
HIV-1-infected mPBMCs. (B) The expression pattern of genes associated the
Wnt/β-catenin signaling pathway. (C) The expression pattern of genes
associated with the NK cell signaling pathway in both HIV-1-infected and
SIV-infected mPBMCs. The gene expression changes that passed a cutoff
p≤0.01 were shown as Up-regulation or Down-regulation. Otherwise, were
shown as Unch. (unchanged). All the gene expression changes were revealed by
macaque-specific oligonucleotide microarrays.
Table 1 (continued)
141Y. Li et al. / Virology 366 (2007) 137–149(Molina et al., 1992; Sloan-Lancaster et al., 1994; Sugie et al.,
2004). In the HIV-1-infected mPBMCs, we observed the
expression changes of 8 genes in the T cell receptor pathway.
Notably, the expression of CD247, ZAP-70, LCK, and FYN
was up-regulated in the HIV-1-infected mPBMCs (Fig. 5A,
Table 1A); the up-regulation of CD247, LCK, and ZAP70 was
also confirmed by qRT-PCR (Fig. 7).
The increased presence of T cell receptor associated
molecules may potentiate T cells for activation or lead to
anergy, depending on the availability of co-stimulation from the
CD28 pathway (Kane et al., 2000). Although we did not
observe the expression changes of the CD28 signaling pathway,
the up-regulation of JUND in the HIV-1-infected mPBMC
suggested that the HIV-1-infected mPBMCs may not be in a
state of anergy, the immuno-nonresponsive status (Supplemen-
tal Table 2) (Heisel and Keown, 2001). Thus, a heightened state
of T cell activation and the transcription programs it triggered
would in turn be in agreement with the increased gene
expression regulation exhibited by HIV-1-infected PMBCs
relative to SIV-infected ones, in spite of the lower replication
levels of HIV-1.
Therefore, our results suggested that T cell activation may be
enhanced in HIV-1-infected mPBMCs. Activated Tcells may be
more effective in mediating host responses against HIV-1
infection, thereby contributing to the lower pathogenicity of
HIV-1 in macaques.
ERK/MAPK signaling pathway
The activation of the T cell receptor pathway would in turn
affect a number of down stream signaling pathways including
the ERK/MAPK pathway (Michie et al., 1999). Interestingly, a
few genes associated with the ERK/MAPK pathway were
differentially expressed only in the HIV-1-infected mPBMCs,
including YWHAH (14-3-3), RAP1A, and MAPK3 (ERK1).
Fig. 5. (A) Networks of pathways unique in the HIV-1 regulated mPBMCs. The networks showing the relationship of genes in the antigen presentation, the T cell
receptor, and the ERK/MAPK pathways are shown. (B) Relationship networks of genes associated with the NK cell signaling pathway in both HIV-1- and SIV-infected
mPBMCs. The networks were built by Ingenuity Pathway Analysis. Each dot represents a gene, with green indicating down-regulation of the gene, and red indicating
up-regulation of the gene. Each line connecting two genes indicates a relationship between the gene products as reported in literature.
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differentially regulating the activities of the MAPK pathways
(Xing et al., 2000). An up-regulation of YWHAH may confer
protective effects on the immune cells during the HIV-1
infection in macaques. The RAP1A protein is important in
mediating T cell anergy by blocking the TCR signals to ERKs
(Boussiotis et al., 1997; Carey et al., 2000). The down-
regulation of RAP1A supported that the HIV-1-infected
mPBMC may not be in an anergy status. Furthermore, the
MAPK3 gene, known to play important roles in T cell
development (Fischer et al., 2005), was up-regulated only in
HIV-1-infected mPBMCs and as confirmed by qRT-PCR (Fig.
7); this up-regulation could be the direct result of the activation
of the T cell receptor pathway (Haks et al., 2005). Given that
ERK pathway plays a critical role during the development of T
cells and the immune selection (Alberola-Ila and Hernandez-
Hoyos, 2003), up-regulation of the ERK signaling pathway
early on during the HIV-1 infection in macaques may enhance
the functions of T cells and consequently induce stronger anti-
viral responses, in turn accounting for the subdued pathogeni-
city of the virus in comparison to SIV.
Taken together, our data suggested that the signaling cascade
from the MHC/TCR interaction to the downstream ERK/
MAPK signaling pathway was up-regulated in the HIV-1-
infected mPBMCs compared to SIV-infected ones. The
heightened state of immune activation may be an indication
of the host's success in warding off HIV-1 infection, resulting inreduced pathogenicity in macaques. However, many genes in
the T cell receptor and the ERK/MAPK pathways, for example
CD247 (CD3-zeta), PLCG2 and MAPK3 (ERK1) itself, are not
exclusively expressed in T cells but also in other cell types such
as B cells and NK cells (Arase et al., 2003; Chiu et al., 2005; Yu
et al., 2000).
Therefore, it is possible that other cell populations in the
mPBMCs, besides T cells, were activated during the HIV-1
infections as well. Given the dominance of immune cells in
PBMC cultures, our results implicated the activation of different
subsets of immune cells.
The activation of these immune cells may be capable of
mediating stronger antiviral immune responses during the HIV-
1 infection compared to the SIV infection in macaques.
Pathway analyses of cellular gene expression profiles in
SIV-infected mPBMCs
Wnt/β-catenin signaling pathway
The Wnt/β-catenin signaling pathway plays important roles
in the survival of T cells (Goux et al., 2005). Our results
indicated that the Wnt/β-catenin signaling pathway may be
repressed in the SIV-infected mPBMCs, as characterized by the
expression changes of 3 key genes in the Wnt/β-catenin
signaling pathway, TCF-4, LEF-1, and PPP2R2B (Hovanes et
al., 2001; Li et al., 2001; Miller and Moon, 1996) (Table 1B).
TCF-4 was shown to have repressive effects on the HIV-1
Fig. 6. HIV-1 infection regulates the expression of a large number of immune
response genes at day 4 p.i. The immune response genes were defined by the
knowledge-based pathway analysis tool, Ingenuity Pathway Analysis. The
expression changes were revealed by macaque-specific oligonucleotide
microarrays. (□) indicates the down-regulated genes and ( ) indicates the
up-regulated genes. Each gene expression changes passed the statistical cutoff
(p≤0.01). The two histograms represent data from signature genes, defined as
having a p≤0.01. The p-value is derived from both the errors in microarray
measurements and the estimated variance among the 3 animals.
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regulation of TCF-4 in the SIV-infected mPBMC, as confirmed
by qRT-PCR (Fig. 7), may contribute to a more robust
replication of SIV than HIV-1 in mPBMCs. LEF-1, shown to
play a critical role in the survival of T cells (Ioannidis et al.,
2001), was also down-regulated in the SIV-infected mPBMCs.
Given that a down-regulation of LEF-1 may impair the CD8+ T
cell development and its functions (Okamura et al., 1998), SIV
may be able to compromise the antiviral functions of the CD8+
T cells by down-regulating the expression of LEF-1 during the
infection in macaques.
Moreover, PPP2R2B (PP2A), known to inhibit the Wnt/β-
catenin pathway (Li et al., 2001), was up-regulated only in
the SIV-infected mPBMCs. Our data therefore suggested that
Wnt/β-catenin signaling pathway may be repressed in the
SIV-infected mPBMCs. Given that the pathogenic SIV
infection in macaques was characterized by increased T cell
death (Batten et al., 2006), the concerted down-regulation of
Wnt/β-catenin signaling pathway, characterized by the down-
regulation of LEF-1 and TCF-4 and the up-regulation of
PPP2R2B, deals a double blow to T cell functions and
survival and may contribute to the pathogenicity of SIV in
macaques.
Natural killer cell signaling pathway
Natural killer (NK) cells play important roles in restraining
the infection of HIV-1 in humans (Fauci et al., 2005; Mavilio et
al., 2003). By extension, we speculated that the NK cell
signaling may be different in the HIV-1-infected and SIV-
infected mPBMCs. Interestingly, we observed the regulation of
the NK signaling pathway in both HIV-1-infected and SIV-
infected mPBMCs, albeit with different patterns (Fig. 5B and
Table 1C). A few NK cell signaling-associated genes were
commonly regulated in both HIV-1 and SIV-infected mPBMCs.
CD244 (2B4), a NK cell receptor that stimulate NK cell
cytotoxicity (Messmer et al., 2006), and SYK, a key gene to NK
cell functions (Jiang et al., 2002), were up-regulated in both
HIV-1- and SIV-infected mPBMCs; the up-regulation of CD244
by both viruses was confirmed by qRT-PCR (Fig. 7). However,
the NK cell marker FCGR3A (CD16), CCL4 and CCL5 (Fig. 7)
were up-regulated in mPBMCs infected with HIV-1, but not
with SIV, suggesting that NK cells may be at a heightened
activation status in the HIV-1-infected mPBMCs (Arase et al.,
2003; Dorner et al., 2004).
Reportedly, NK cells are able to repress the HIV-1 infection
in human cells by secreting large amounts of CCL4 and CCL5
to block the entry of HIV-1 (Fehniger et al., 1998). However,
given that CCL5 only blocks the infection of the M-tropic
HIV-1 but not the T-tropic HIV-1 used in this study, blocking
the entry of HIV-1 by CCL5 may not entirely account for the
low pathogenicity of this specific HIV-1 strain in macaques.
Recent studies suggested that NK cells play crucial roles in
connecting the innate and adaptive immune responses (Cooper
et al., 2004; Degli-Esposti and Smyth, 2005; Moretta, 2002).
Therefore, activated NK cells may play roles in coordinating
other immune cells to effectively repress the HIV-1 infection in
macaques and contribute to the reduced HIV-1 pathogenicityindirectly (Gerosa et al., 2002; Groot et al., 2006; Piccioli et
al., 2002).
HIV-1 infection induces earlier and stronger immune response
than the SIV infection in mPBMCs
The pathway analyses described above revealed that the
infections of HIV-1 and SIV induced changes in largely distinct
sets of pathways. It should be noted that the expression changes
of these pathways could take place in more than one cell
population. For instance, the antigen presentation pathways
could appear in different types of dendritic cells (DCs).
The T cell receptor pathway may be affected in CD4+ T cells
and/or CD8+ T cells. Furthermore, the intracellular signaling
pathways such as the ERK and the Wnt/β-catenin signaling
pathways are functional not only in T cells (Tan et al., 2006) but
also in B cells and other immune cells (Guo and Rothstein,
2005; Yu et al., 2000). By design, gene expression profiling
does not single out individual cell populations that are affected
by the expression of these pathways; instead, the analysis
reveals changes in the transcriptional program associated with
the virus infections. Notably, using IPA, we observed differ-
ential expression predominantly among genes involved in
immune response. Thus, we attempted to examine the expres-
sion pattern of the immune response genes as a whole between
the HIV-1-infected and SIV-infected mPBMCs.
Interestingly, our results suggested that HIV-1 infection
induced expression changes of immune response genes earlier
on and to a greater extent than SIV infection in mPBMCs (Fig.
6). Based on annotations in the IPA knowledgebase, we
identified 187 immune response genes (Supplemental Table 2)
from our list of ∼1300 differentially expressed genes in HIV-1-
infected and SIV-infected mPBMCs (Supplemental Table 4).
Overall, immune response genes had expression changes in the
HIV-1-infected mPBMCs, in contrast to 91 immune response
genes in the SIV-infected cells. Interestingly, 95 genes were
regulated by HIV-1 infection on day 4 p.i., only 25 immune
144 Y. Li et al. / Virology 366 (2007) 137–149genes were changed in SIV-infected mPBMCs at the same time
point. In other words, the HIV-1 infection induced about 4 times
as many immune response genes as the SIV infection did on day
4 p.i. On day 6 p.i., HIV-1 and SIV induced expression changes
of 71 and 76 immune response genes, respectively. Given that
the HIV-1 replication is significantly lower than that of SIV on
both days 4 and 6 p.i., our expression profiling results of
immune response genes therefore suggested that the HIV-1
infection induced a more robust and prompt immune response
than the SIV infection.
Previous studies have suggested that chronic immune
activation is a major characteristic of the pathogenic HIV-1
and SIV infections in vivo (Folks et al., 1997; George et al.,
2006; Giorgi et al., 1999; Onanga et al., 2006). However, our
molecular profiling data from the HIV-1-infected mPBMCs
described a different scenario by suggesting that the HIV-1
infection may induce a better controlled immune activation in
macaques. HIV-1 infection in mPBMCs transiently induced the
expression changes of a few key genes that are crucial in
controlling the activation of immune cells. CD247, ZAP70, and
LCK, known to be expressed in multiple immune cells, wereFig. 7. qRT-PCR confirmation of the microarray results. The expression changes of se
the virus-infected cells relative to the time-matched mock-infected cells were calculup-regulated only at day 4 p.i. but not at the later time point
(Supplemental Table 2); on the other hand, CTLA-4, a repressor
of T cell activation critical to regulating immune cell activities
(Schneider et al., 2006) and the overall immune response (Rudd
and Schneider, 2003), was down-regulated on day 4 but not on
day 6 p.i. in the HIV-1-infected mPBMCs, as confirmed by
qRT-PCR (Fig. 7). The transient down-regulation of CTLA-4 in
the HIV-1-infected mPBMCs at the early time point is in line
with the enhanced T cell receptor signaling we observed at the
same time point and provides further evidence for T cell
activation at this earlier time point. On the other hand, the
recovery of CTLA-4 expression on day 6 p.i. and the concurrent
down-350 regulation of ICOS, an inducer of T cell activation
(Nurieva et al., 2003), indicate that activation of these immune
cells is not persistent. In contrast, SIV-infected mPBMCs did
not exhibit comparable decrease in T cell activation, as the
repressor CTLA-4 stayed down-regulated on both days 4 and
6 p.i., with the inducer ICOS unaffected by SIV infection.
Taken together, our data indicated that HIV-1 and SIV
infections were associated with distinct T cell activation states:
HIV-1 appears to first induce and then suppress Tcell activation,lected genes were also quantified by qRT-PCR assay. The expression changes in
ated.
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4 p.i.; HIV-1 replication was subsequently subdued at later
time points, as T cell activation is required for efficient HIV
replication (Gowda et al., 1989); in contrast, SIV-1 does not
appear to effect a similar suppression on T cells and therefore
may support more robust virus replication.
The distinct pathogenic properties of HIV-1 and SIV in
macaques are likely to be caused by multiple factors. Persistent
activation and the activation induced cell death (AICD) of
immune cells have been reported extensively as a key to the
HIV-1 pathogenesis in humans (Grossman et al., 2006). Unlike
the pathogenic infection in humans, HIV-1 infection may only
temporally induce the activation of immune cells in macaques.
The temporal immune activation could be robust enough to
hinder the progression of infection by antiviral immune
responses but not enough to induce massive cell death in
macaques. The other reason could be a failure of the macaques
to mount an effective immune response in spite of robust SIV
replication at the early stage of infection. Unlike the SIV
infection, a low level replication of HIV-1 would be able to
trigger a robust immune response in macaque. It is conceivable
that the immune activation can be triggered by both direct and
indirect mechanisms. Specifically, we speculate that the
temporal surge in the release of cytokines by the HIV-infected
cells (Bahbouhi et al., 2004), albeit in the minority, can signal
gene expression changes in bystander cells in a paracrine
fashion. Evading the immune surveillance is one well adopted
strategy of primate lentiviruses during pathogenic infections
(Evans and Desrosiers, 2001). One well studied example is nef,
a gene encoded by all primate lentiviruses. Nef plays a central
role in the evasion of host immune surveillance (Fackler and
Baur, 2002). The pathogenicity of SIV with defects in the nef
gene is significantly compromised in macaques (Kestler et al.,
1990). A recent study suggested that, unlike SIV Nef, HIV-1
Nef does not suppress the immune cell activation (Schindler et
al., 2006). Given that the Nef is dominantly expressed at the
very early stage during the SIV infection, the repressive role of
Nef in the immune activation could be crucial to the
pathogenicity of SIV in macaques. Therefore, a failure of
suppressing the immune cell activation by HIV-1 Nef may
allow for rapid antiviral immune response to take effect during
the HIV-1 infection in macaques.
In conclusion, our results indicated that the infection of HIV-
1 and SIV in mPBMCs induced distinct pattern of cellular gene
expression changes. While HIV-1 and SIV exhibited similar
replication rates up until day 4 p.i., noticeable differences in
host gene expression observed from that point on suggested that
the pathogenic potential of the viruses could be reflected in the
transcriptional programs triggered by the infections. Specifi-
cally, HIV-1 infection transiently triggered enhanced antigen
presentation, as well as signaling and activation of T cells and
NK cells at the early time point. By comparison, SIV infection
was associated repressed T cell activation via Wnt/β-catenin
signaling. HIV-1 infection induced more robust cellular res-
ponse, possibly able to keep HIV-1 replication in check earlier
on. However, as the infection progresses, the immune response
is modulated, as seen in the lessened T cell activation at the latetime point, which may render the susceptible cells less permi-
ssive to virus replication. The failure to sustain robust virus
production caused by the host antiviral immune responses may
partially explain the low pathogenicity of HIV-1 in macaques;
unlike HIV-1, SIV is likely to have acquired the necessary
fitness through evolution to sustain replication via the more
expedient repression of host immune response. To reveal the
restrained pathogenicity of HIV-1 in macaques mechanistically,
further studies should focus on the investigation of the roles of




Peripheral blood was collected from three healthy pigtail
macaques at Washington National Primate Research Center.
Macaque PBMCs were recovered by standard Ficoll density-
gradient centrifugation. The recovered cells were then washed,
counted, and placed at a density of 2×106 cells/ml in complete
RPMI 1640 growth medium containing 10% fetal bovine serum
and 5% lectin-purified IL-2 (Roche Diagnostics). Phytohemag-
glutinin (Sigma Chemical) was then added at a concentration of
5 g/ml, and after a 24 h incubation period, the medium was
replaced with fresh complete medium and the culture was
incubated at 37 °C for 4 days prior to infections.
Virus
The SIV strain, SIVmac239, containing an open reading
frame of the nef gene was produced from two plasmids
p239SpSp5′ and p239SpE3′Nef open (The NIH AIDS Research
and Reference Reagent Program) as described previously (Gibbs
et al., 1994). The HIV-1 strain, HIV-1 Lai, was the lab stock
originally obtained from the Institute Pasteur, France (Peden et
al., 1991). The SIV stock was grown in CEMx174 cells and the
HIV-1 stock grown in CEMss cells. Both virus stocks were
filtered through 0.22 m filters to remove cell derbies prior to the
infections. The infectious titers of HIV-1 and SIV were
determined in CEMx174 cells by the end-point dilution assays
(Rodrigo et al., 1997).
Virus infection
Unfractionated mPBMCs (10×106 cells) from 3 pigtail
macaques showed comparable compositions in terms of the cell
types present (Supplemental Table 1). The mPBMCs from each
individual animal were infected with HIV-1 or SIV at a
multiplicity of 1 TCID50/cell or mock-infected with a volume of
culture supernatant from uninfected cells equal to the volume of
virus stocks. After a 120 min incubation period at 37 °C,
unattached virus was removed by 3 washes with phosphate-
buffered saline. Mock-infected cells were washed in the same
manner. The cells were then divided in 24-well tissue culture
plates at 0.5×106 cells/well in 2 ml of complete medium per
well per animal. For each animal, 2 wells of cells infected with
146 Y. Li et al. / Virology 366 (2007) 137–149each virus or mock were harvested on days 2, 4, 6, and 8 p.i.
Cells were counted at harvesting and the percentage of viable
cells was determined by trypan blue dye exclusion. The cells
were then collected by centrifugation and lysed in buffer RLT
from RNeasy RNA isolation kit (Qiagen, CA). Culture super-
natants were monitored for p27 or p24 levels by antigen-capture
ELISA (ZeptoMetrix Corp. NY). The percentage of infected
cells was estimated by indirect immunofluorescence assay (IFA)
using pooled sera from SIV-infected macaques or HIV-1-
infected humans as described previously (Agy et al., 1991).
Microarray analyses
For oligonucleotide array analyses, total RNA was isolated
by RNeasy RNA isolation kit (Qiagen, CA). Equal amount of
RNA isolated from 2 duplicate wells was combined before the
complimentary RNA (cRNA) amplification. The cRNA was
then amplified using the Agilent low RNA input linear ampli-
fication kit (Agilent Technologies, CA). The quantity and
quality of cRNA were evaluated by capillary electrophoresis
using an Agilent Technologies 2100 Bioanalyzer. Probe label-
ing and microarray hybridizations were performed as described
in the Agilent 60-mer oligo microarray processing protocol
(Agilent Technologies, CA). Labeled probes derived from SIV-
infected cells, HIV-1-infected cells, and their time matched
mock-infected controls were co-hybridized against the probes
derived from a common reference RNA sample on the Agilent
macaque oligonucleotide microarrays (Version 2) (Agilent
Technologies, CA). The common reference RNA was pooling
RNA isolated from mPBMCs of 10 uninfected pigtail macaques
excluding the animals used in this study and the common
reference probes were produced in the same fashion as the other
probes. Slides were scanned with an Agilent microarray scanner
and image analysis was performed using Agilent Feature Ex-
tractor Software. Each microarray experiment was done using a
dye-swapping technique, thereby providing 2 technical repli-
cates for each measurement (Kerr and Churchill, 2001).
All data were entered into a custom-designed database,
Expression Array Manager, and then uploaded into Resolver
5.0 (Rosetta Biosoftware, WA) for analyses. The expression
value of each individual gene was the average of 3 expression
values from 3 animals calculated by the Resolver software
using the Rosetta error model (Weng et al., 2006). For
determining differential expression, the p-value for any given
gene represents contributions from both the variance among
measurements from the 3 animals, as well as the estimated
errors in microarray signal measurements. Initially, genes were
selected as differentially expressed based on a criterion of a
greater than 99% probability of being differentially expressed
(p≤0.01). Biological gene sets (referred to as Biosets) were
compiled for various cellular processes by selecting genes of
interest that were both represented on the microarray and
which had Gene Ontology (GO) annotation (Gene Ontology
Consortium, 2004). Once compiled, Biosets were used to
characterize and compare gene expression patterns between
experiments. These Biosets were also analyzed using the
Ingenuity Pathway Analysis (IPA) Software (www.ingenuity.com, Ingenuity Systems, CA) to assign functional information
and biological relevance to the groups of genes being
regulated. In accordance with proposed standards (Brazma et
al., 2001), all data described in this report, including sample
information, intensity measurements, gene lists, error analysis,
microarray content, and slide hybridization conditions, are
available in the public domain through Expression Array
Manager at http://www.expression.washington.edu/public.
qRT-PCR
Quantitative real-time PCR (rtPCR) was used to verify the
gene expression changes. Total RNA samples were treated with
DNase using DNA-free DNase Treatment and Removal
Reagents (Ambion Inc. TX). Reverse Transcription was
performed using TaqMan Reverse Transcription Reagents
(Applied Biosystems, CA). Primer and probe sets for each of
the target sequences were designed using macaque EST
sequences available from Macaque.org (Supplemental Table
3) and mapping them to the M. mulatta genome available from
Baylor College of Medicine. rtPCR was performed on the ABI
7500 Real-time PCR System using TaqMan chemistry (Applied
Biosystems, CA). Each target was run in quadruplicate, with
20 μL reaction volumes of TaqMan 2× PCR Universal Master
Mix (Applied Biosystems, CA). 18S RNA was chosen as
endogenous control to normalize quantification of the targets.
The relative quantification of the viral genome RNA was
performed by using the SIV-3′LTR primer/probe set and the
HIV-1-3′LTR primer/probe set (Supplemental Table 3). The
relative quantification of SIV or HIV-1 genome RNA of each
time point was calculated by using the quantity of the cor-
responding virus genome RNA from day 2 p.i. as the base line.
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